Lung Nodule: Types, Causes, Symptoms, and Treatment

A lung nodule is a small spot in the lung that is usually discovered on a chest X-ray or CT scan performed for another reason. Learning that you have a lung nodule can be unsettling, but most nodules are not cancer.

Many are caused by previous infections, inflammation, or scar tissue. Still, some require follow-up because their size, appearance, or growth pattern may suggest a higher risk.

Understanding how lung nodules are evaluated can help you prepare for follow-up appointments and make informed decisions with your healthcare provider.

What Is a Lung Nodule?

A lung nodule is a small, localized area of abnormal tissue within the lung. It may also be called a pulmonary nodule. On an imaging test, a nodule generally appears as a round or oval spot that is denser than the surrounding air-filled lung tissue.

Lung nodules are usually defined as areas measuring up to 3 centimeters, or about 1.2 inches, across. An abnormal area larger than 3 centimeters is generally described as a lung mass rather than a nodule. A mass has a higher likelihood of being cancerous, although imaging alone cannot always determine the cause.

Nodules may occur in either lung and in any lobe. A person may have one nodule, known as a solitary pulmonary nodule, or multiple nodules. They may be located near the outer surface of the lung, deep within the lung tissue, or close to a blood vessel or airway.

Most lung nodules do not interfere with breathing because they are too small to affect a meaningful amount of functioning lung tissue. They are often discovered incidentally when imaging is performed for chest pain, pneumonia, trauma, heart disease, persistent coughing, shortness of breath, or another medical concern.

Lung nodules are also commonly identified during low-dose CT screening for lung cancer. Screening can detect very small abnormalities that would not be visible on a standard chest X-ray. Although screening can help identify cancer at an earlier stage, it also detects many harmless nodules that need to be evaluated or monitored.

Most lung nodules are benign, meaning they are not cancerous. Common benign causes include healed infections, inflammation, scar tissue, and noncancerous growths. The challenge is identifying the smaller percentage of nodules that may represent early lung cancer.

How Common Are Lung Nodules?

Lung nodules are common, particularly among older adults, people who currently smoke or previously smoked, and people who live in areas where certain fungal infections are widespread. They are also found in people who have never smoked and have no known lung disease.

The increasing use of CT imaging has made lung nodules more frequently detected. CT scans can reveal nodules only a few millimeters wide, including spots that may have been present for years without causing symptoms or health problems.

Finding a nodule does not mean that a person has lung cancer. In fact, most nodules found through screening or imaging are ultimately determined to be benign. In the National Lung Screening Trial, many participants had findings that appeared suspicious enough to require further evaluation, but the large majority of those findings were not cancer.

A person’s individual risk cannot be determined from prevalence statistics alone. The likelihood of cancer depends on several factors, including age, smoking history, nodule size, nodule type, shape, location, growth, and medical history.

What Causes Lung Nodules?

A lung nodule is an imaging finding rather than a specific disease. Many different conditions can create a small spot in the lung.

Previous Lung Infections

Past infections are among the most common causes of benign lung nodules. When the immune system responds to an infection, it may create a localized collection of inflammatory cells. After the infection resolves, a small area of scar tissue or a calcified granuloma may remain.

Infections associated with nodules may include:

• Tuberculosis
• Histoplasmosis
• Coccidioidomycosis
• Blastomycosis
• Aspergillosis
• Bacterial pneumonia
• Other previous fungal or bacterial infections

A granuloma is a small cluster of immune cells that forms when the body attempts to isolate a substance it cannot easily remove. Granulomas often become calcified over time. Certain patterns of calcification can strongly suggest that a nodule is benign.

People may not remember having the infection that caused a granuloma. Some infections produce mild symptoms or no noticeable symptoms but still leave a small mark on lung imaging.

Active Infections

An active infection can sometimes produce one or more nodules. These nodules may be accompanied by fever, coughing, fatigue, mucus production, chest discomfort, or other symptoms of infection.

Infectious nodules may shrink or disappear after the infection resolves. A clinician may recommend treating the suspected infection and repeating the CT scan after an appropriate interval to confirm that the abnormality has improved.

Not every nodule should automatically be treated with antibiotics. The imaging appearance, symptoms, laboratory results, exposure history, and overall health of the patient must support infection as a likely cause.

Inflammation

Inflammatory conditions can create nodules even when no infection is present. Inflammation may cause immune cells and scar tissue to accumulate in localized areas of the lung.

Conditions that may be associated with inflammatory nodules include:

• Rheumatoid arthritis
• Sarcoidosis
• Granulomatosis with polyangiitis
• Certain autoimmune diseases
• Inflammatory reactions to inhaled substances

Rheumatoid nodules, for example, can occur in some people with rheumatoid arthritis. Sarcoidosis may cause multiple nodules along with enlarged lymph nodes in the chest. Granulomatosis with polyangiitis may produce nodules that occasionally develop cavities.

The person’s symptoms, blood tests, medical history, and the distribution of nodules on CT can help clinicians identify an inflammatory cause.

Scar Tissue

Scar tissue may form after an infection, injury, surgery, radiation therapy, or long-term inflammation. A small scar can resemble a nodule on imaging.

Some scars remain stable throughout a person’s life. Stability over time is reassuring, especially when the nodule has shown no meaningful change on CT scans performed several years apart.

A scar and a cancerous nodule can sometimes have similar appearances. This is one reason previous imaging is so valuable. Comparing current and earlier scans can show whether a spot is new, growing, shrinking, or unchanged.

Noncancerous Tumors

Some nodules are benign tumors. A common example is a pulmonary hamartoma. A hamartoma consists of an unusual mixture of normal tissues, such as cartilage, fat, connective tissue, and smooth muscle.

Certain imaging features may suggest a hamartoma, including the presence of fat or a characteristic pattern of calcification. A typical hamartoma may not require treatment if the diagnosis is clear and it is not causing symptoms.

Other uncommon benign tumors may arise from nerve tissue, connective tissue, smooth muscle, or other structures within the lung.

Lung Cancer

A lung nodule can represent an early lung cancer. Cancerous nodules develop when abnormal cells grow uncontrollably and form a localized lesion.

Both major categories of primary lung cancer can present as nodules:

• Non-small cell lung cancer
• Small cell lung cancer

Non-small cell lung cancer is much more likely to appear initially as a solitary nodule. Adenocarcinoma, a type of non-small cell lung cancer, frequently begins in the outer regions of the lung and may appear as a solid, part-solid, or ground-glass nodule.

A cancerous nodule may remain small and cause no symptoms, particularly during its early stages. This is why imaging follow-up is important when the nodule’s characteristics or the person’s risk factors raise concern.

Cancer That Has Spread to the Lungs

Cancer that begins elsewhere in the body can spread to the lungs and form one or more nodules. This is known as pulmonary metastasis.

Cancers that commonly spread to the lungs include cancers of the:

• Breast
• Colon or rectum
• Kidney
• Head or neck
• Thyroid
• Skin, particularly melanoma
• Bone or soft tissue

Multiple nodules can raise concern for metastatic disease in someone with a known history of cancer. However, multiple nodules can also result from infection, inflammation, or other noncancerous conditions.

Note: A previous cancer diagnosis is important when assessing risk, but it does not prove that a new lung nodule is metastatic.

Other Causes

Less common causes of nodular lung findings include vascular abnormalities, areas of bleeding, inhaled material, congenital abnormalities, rounded areas of collapsed lung, and mucus trapped within an airway.

Occasionally, a structure outside the lung may project over the lung on a chest X-ray and look like a nodule. Examples include a nipple shadow, a skin lesion, a rib abnormality, or an external object. CT imaging can usually determine whether the finding is actually within the lung.

Types of Lung Nodules

Lung nodules are classified according to their density, size, shape, margins, internal features, and relationship to nearby structures.

Solid Nodules

A solid nodule is dense enough to completely obscure the lung markings behind it on a CT image. Solid nodules are the most common type.

They may result from:

• Healed infections
• Granulomas
• Scar tissue
• Hamartomas
• Active infections
• Primary lung cancer
• Metastatic cancer

Note: The risk associated with a solid nodule depends on its size, growth, shape, and the person’s clinical risk factors. A very small solid nodule in a low-risk person may require no routine follow-up, while a larger or suspicious nodule may need repeat imaging, PET/CT, biopsy, or surgical evaluation.

Ground-Glass Nodules

A ground-glass nodule appears hazy on CT. It increases the density of the lung but does not completely hide the blood vessels and airways passing through it.

Ground-glass nodules may be temporary or persistent. Temporary causes include infection, inflammation, bleeding, or partial collapse of tiny air spaces. Persistent ground-glass nodules may represent scar tissue, a precancerous change, or a slow-growing form of adenocarcinoma.

Because some cancerous ground-glass nodules grow very slowly, they may need to be monitored for a longer period than many solid nodules. Stability for only a few months may not be enough to establish that a persistent ground-glass nodule is harmless.

Part-Solid Nodules

A part-solid nodule contains both a ground-glass area and a denser solid component. These nodules deserve careful evaluation because persistent part-solid nodules can be associated with early lung adenocarcinoma.

The size of the solid component is particularly important. An increasing or enlarging solid portion may indicate that the lesion is becoming more invasive.

Inflammation and infection can also cause part-solid findings, so an initial short-term follow-up scan may sometimes be recommended to determine whether the nodule persists.

Calcified Nodules

Calcification means calcium has accumulated within a nodule. Certain calcification patterns strongly support a benign diagnosis, particularly when the calcium is centrally located, evenly distributed, layered, or arranged in a pattern commonly seen in hamartomas.

Not all calcified nodules are automatically benign. Irregular or off-center calcification may occur in malignant nodules. The radiologist evaluates the specific pattern rather than simply noting whether calcium is present.

Cavitary Nodules

A cavitary nodule contains an air-filled space. Cavitation may occur when tissue inside the nodule breaks down.

Possible causes include:

• Bacterial infection
• Fungal infection
• Tuberculosis
• Autoimmune disease
• Squamous cell lung cancer
• Metastatic disease

Note: The thickness and irregularity of the cavity wall, along with symptoms and other imaging findings, can help narrow the possibilities. Neither a thin wall nor a thick wall can establish the diagnosis by itself.

Perifissural Nodules

Perifissural nodules are found near the fissures that separate the lobes of the lungs. Many represent small intrapulmonary lymph nodes.

They often have a smooth, triangular, oval, or lentil-like shape. A typical perifissural nodule is usually considered benign, although the radiologist must confirm that its appearance and location are characteristic.

Solitary and Multiple Lung Nodules

A solitary pulmonary nodule is a single nodule surrounded by lung tissue. A solitary nodule may be caused by a granuloma, scar, benign tumor, primary lung cancer, or another localized process.

Multiple nodules create a broader list of possible causes. Their number, distribution, size, and similarity provide useful clues.

Multiple nodules may be associated with:

• Previous fungal infections
• Active infection
• Sarcoidosis
• Rheumatoid arthritis
• Occupational lung disease
• Metastatic cancer
• Multiple primary lung tumors
• Inflammation of blood vessels

Clinicians also look at whether the nodules are concentrated in one area or scattered throughout both lungs. Nodules arranged along airways may suggest a different process from nodules distributed through the bloodstream.

Note: The largest or most suspicious nodule often guides management, but the overall pattern must also be considered.

Do Lung Nodules Cause Symptoms?

Most lung nodules do not cause symptoms. They are generally too small to affect airflow, oxygen exchange, or lung capacity. A person can have a nodule for years without feeling it.

When symptoms are present, they are often caused by the underlying condition rather than by the nodule itself. For example, an infection responsible for a nodule may cause coughing and fever, while an inflammatory disease may cause fatigue or joint symptoms.

Possible symptoms associated with an underlying lung condition include:

• A persistent or worsening cough
• Coughing up blood
• Shortness of breath
• Wheezing
• Chest pain
• Fever or chills
• Recurrent respiratory infections
• Unexplained weight loss
• Loss of appetite
• Persistent fatigue
• Hoarseness

These symptoms do not necessarily mean that a nodule is cancerous. Many common respiratory illnesses produce similar symptoms. However, persistent, unexplained, or worsening symptoms should be evaluated rather than attributed to a small imaging finding without further assessment.

Lung cancer may not cause symptoms in its early stages. When symptoms develop, they can include a new cough, chest pain, coughing up blood, hoarseness, shortness of breath, or wheezing.

How Lung Nodules Are Found

Chest X-Ray

A chest X-ray can identify some lung nodules, particularly those that are relatively large or dense. The finding may appear as a white spot against the darker background of the air-filled lungs.

Chest X-rays have limitations. Small nodules may be hidden by the heart, ribs, blood vessels, or other structures. An apparent nodule may also be caused by overlapping anatomy outside the lung.

When a chest X-ray shows a possible nodule, a chest CT is commonly recommended. CT provides much more detail and can confirm the nodule’s location, size, density, and shape.

Computed Tomography

CT is the main imaging method used to evaluate lung nodules. It produces detailed cross-sectional images and can detect abnormalities only a few millimeters wide.

A CT scan can show:

• Exact nodule size
• Whether the nodule is solid or subsolid
• Margin characteristics
• Calcification
• Fat within the nodule
• Cavitation
• Relationship to blood vessels and airways
• Enlarged lymph nodes
• Additional nodules
• Other lung abnormalities

Note: Thin-section CT images are especially useful for nodule evaluation. Follow-up scans are often performed with a low-dose technique to reduce radiation exposure while still allowing accurate comparison.

Lung Cancer Screening

Low-dose CT screening is intended for people who have a high risk of lung cancer but do not have symptoms. Eligibility is based primarily on age and smoking history.

Screening is different from diagnostic testing. Screening looks for disease before symptoms appear, while diagnostic imaging investigates an existing symptom or abnormal finding.

A screening program generally uses a standardized reporting system to categorize nodules and recommend appropriate follow-up. Nodules detected outside screening programs may be managed according to separate incidental nodule guidelines.

What Features Make a Lung Nodule More Concerning?

No single imaging feature can determine with certainty whether a nodule is cancerous. Clinicians combine the imaging findings with personal risk factors to estimate the probability of cancer.

Size

Nodule size is one of the strongest predictors of risk. In general, larger nodules are more concerning than smaller ones.

Size does not provide a diagnosis. A small nodule can occasionally be cancerous, and a large nodule can be benign. However, very small nodules have a lower average likelihood of malignancy than larger nodules.

Radiologists measure nodules carefully in millimeters. Some centers also use computer software to calculate nodule volume, which may detect growth more accurately than measurements in one or two dimensions.

Growth

Growth over time is an important warning sign. Comparing the current scan with previous images helps determine whether the nodule has changed.

Growth may involve:

• An increase in overall diameter
• An increase in volume
• Development of a solid component
• Enlargement of an existing solid component
• A change in shape or density

A nodule can appear slightly different because of breathing, patient positioning, scan technique, or measurement variation. Clinicians generally look for a meaningful change rather than relying on a very small difference between reports.

Rapid growth can suggest infection or inflammation, although some aggressive cancers also grow quickly. Slow growth can occur with certain lung cancers, particularly subsolid adenocarcinomas. Therefore, the speed of growth must be interpreted together with the nodule type.

Margins

Smooth, well-defined borders are often reassuring, but they do not guarantee that a nodule is benign.

Irregular, lobulated, or spiculated margins may increase concern. A spiculated nodule has thin strands extending into the surrounding lung tissue. Spiculation can occur when a tumor pulls on nearby tissue, although scarring and inflammation can produce a similar appearance.

Density

The radiologist considers whether the nodule is solid, ground-glass, or part-solid. Persistent part-solid nodules and some persistent ground-glass nodules may be associated with early adenocarcinoma.

The density must be considered along with size and duration. A temporary ground-glass nodule caused by infection carries a very different implication from one that remains present and gradually develops a solid component.

Location

Some primary lung cancers are more frequently found in the upper lobes. An upper-lobe location may modestly increase concern when combined with other risk factors.

Location alone is not enough to diagnose cancer. Benign scars and granulomas also commonly occur in the upper lungs.

Calcification and Fat

Benign patterns of calcification and visible fat can be reassuring. Fat within a nodule may suggest a hamartoma. Dense, central, or evenly distributed calcification may suggest a healed granuloma.

Suspicious nodules can occasionally contain calcification, so the pattern and overall appearance matter.

Enlarged Lymph Nodes

Enlarged lymph nodes in the chest can occur with infection, inflammation, or cancer. Their presence may affect the recommended evaluation, particularly when a suspicious nodule is also present.

A PET/CT scan, bronchoscopy, needle biopsy, or surgical procedure may be used to sample an enlarged lymph node when the result would help establish a diagnosis or determine whether cancer has spread.

Personal Risk Factors for Lung Cancer

The same nodule may be handled differently in two people because their baseline cancer risks are different.

Important risk factors include:

• Older age
• Current or previous cigarette smoking
• A greater total smoking exposure
• Exposure to radon
• Exposure to asbestos or other workplace carcinogens
• A personal history of lung cancer
• A history of another cancer
• A family history of lung cancer
• Chronic obstructive pulmonary disease
• Pulmonary fibrosis
• Certain suspicious imaging features

Smoking history is often measured in pack-years. One pack-year means smoking an average of one pack per day for one year. For example, smoking two packs per day for 15 years equals 30 pack-years.

People who have never smoked can still develop lung cancer. Radon, secondhand smoke, occupational exposures, air pollution, genetic factors, and other influences may contribute.

A low-risk person is generally younger, has little or no smoking history, and lacks major cancer risk factors. A high-risk person may be older, have a substantial smoking history, or have other clinical and imaging features associated with malignancy.

What Happens After a Lung Nodule Is Found?

The next step depends on how the nodule was discovered, its size and type, the person’s risk factors, and whether previous scans are available.

Review of Previous Imaging

One of the first steps is locating older chest X-rays or CT scans. A scan from several years earlier can provide valuable information.

A nodule that has remained unchanged for an appropriate period may be considered benign, depending on its type. Solid nodules are generally assessed differently from subsolid nodules because ground-glass and part-solid cancers may grow more slowly.

Older imaging may be stored at another hospital or imaging center. Patients can help by telling their clinician where previous studies were performed so that the actual images, not only the written reports, can be requested.

Clinical Risk Assessment

The healthcare provider reviews the patient’s:

• Age
• Smoking history
• Previous cancer history
• Family history
• Occupational and environmental exposures
• Symptoms
• Recent infections
• Travel or geographic history
• Immune system status
• Other medical conditions

The clinician then combines this information with the radiologist’s description. Some practices use validated risk prediction calculators to estimate the probability that a nodule is malignant.

A calculator can support decision-making, but it does not replace clinical judgment. Risk models may not be appropriate for every patient or every type of nodule.

Follow-Up CT Scans

Many small nodules are managed with CT surveillance. The purpose is to determine whether the nodule disappears, remains stable, or grows.

Follow-up may be recommended after a few months, six months, one year, or a longer interval. The exact schedule varies according to the nodule’s size, density, risk category, and the guideline being used.

A short-term CT may be performed when infection or inflammation is possible. Longer surveillance may be needed for persistent subsolid nodules because some grow very slowly.

Not every small nodule requires routine follow-up. In some low-risk situations, the estimated likelihood of cancer is so small that further imaging could expose the patient to cost, anxiety, and radiation without providing meaningful benefit.

Note: Current recommendations for incidental nodules generally use nodule size and patient risk to determine whether follow-up CT, PET/CT, biopsy, or no additional imaging is appropriate.

PET/CT Scan

A positron emission tomography and computed tomography scan, commonly called PET/CT, measures metabolic activity while also showing anatomy.

Before the scan, a small amount of a radioactive glucose-like tracer is injected. Cells that use more glucose may absorb more tracer and appear more active.

Cancer cells often have increased metabolic activity, but a positive PET result does not prove cancer. Infection and inflammation can also absorb the tracer. Likewise, some cancers have low metabolic activity and may not appear strongly positive.

PET/CT has limitations with small nodules because the scanner may not accurately evaluate lesions below a certain size. It may be less helpful for small ground-glass nodules or certain slow-growing cancers.

Note: A PET/CT may also evaluate lymph nodes or other parts of the body when cancer is suspected.

Biopsy

A biopsy removes cells or tissue so that a pathologist can examine them under a microscope. Biopsy is generally considered when the probability of cancer is high enough to justify an invasive procedure and the result is expected to affect treatment.

The safest and most effective biopsy method depends on the nodule’s location and the patient’s health.

Types of Lung Nodule Biopsy

CT-Guided Needle Biopsy

During a CT-guided biopsy, a radiologist advances a needle through the chest wall and into the nodule while using CT images for guidance.

This method is often used for nodules near the outer portion of the lung. Local anesthetic is used to numb the skin and deeper tissues.

Potential complications include:

• Pneumothorax, or collapsed lung
• Bleeding into the lung
• Coughing up blood
• Pain
• Infection

Note: A small pneumothorax may only require observation. A larger one may require insertion of a chest tube to remove air and allow the lung to re-expand. A needle biopsy may occasionally produce an inconclusive result if the sample is too small or does not contain the abnormal tissue.

Bronchoscopy

Bronchoscopy involves passing a thin, flexible tube through the mouth or nose and into the airways. The procedure may be performed with sedation or anesthesia.

Traditional bronchoscopy works best for nodules close to larger airways. Advanced navigation systems can help clinicians reach smaller nodules farther into the lung.

Techniques may include:

• Electromagnetic navigation bronchoscopy
• Robotic bronchoscopy
• Radial endobronchial ultrasound
• Fluoroscopy
• Cone-beam CT guidance

Bronchoscopy can also sample lymph nodes using endobronchial ultrasound. This may be helpful when the diagnosis and cancer staging need to be addressed during the same procedure.

Possible risks include bleeding, infection, low oxygen levels, reactions to sedation, and pneumothorax. The exact risk depends on the biopsy technique and the patient’s medical condition.

Surgical Biopsy

Surgical removal may be recommended when a nodule has a high probability of cancer, when less invasive biopsies are inconclusive, or when the nodule can be diagnosed and treated during the same operation.

Video-assisted thoracic surgery and robotic thoracic surgery use small incisions and a camera. The surgeon may remove the nodule, a wedge of lung tissue, a segment, or an entire lobe, depending on the findings.

A pathologist may examine the tissue during surgery. If cancer is confirmed, the surgeon may proceed with a larger resection and lymph node sampling when appropriate.

Surgery provides a larger tissue sample but carries greater risks than needle biopsy or bronchoscopy. Lung function, heart health, age, and other medical conditions must be assessed before an operation.

Can Blood Tests Diagnose a Lung Nodule?

Routine blood tests cannot reliably determine whether a lung nodule is cancerous. Blood testing may still be useful when infection, inflammation, or autoimmune disease is suspected.

Possible tests include:

• Complete blood count
• Tests of inflammation
• Tuberculosis testing
• Fungal tests
• Autoimmune antibody testing
• Kidney and liver function tests before procedures

Specialized blood-based biomarker tests are being studied and may be used in selected clinical settings. These tests are intended to refine risk estimates rather than provide a stand-alone diagnosis.

A reassuring blood test should not override concerning growth or imaging findings. Similarly, an abnormal biomarker result does not establish cancer without appropriate clinical confirmation.

How Are Lung Nodules Treated?

Treatment depends on the cause. Many nodules require observation rather than immediate treatment.

Benign Nodules

A nodule that has a clearly benign appearance or has remained stable for the required surveillance period may not need further testing or treatment.

The nodule usually does not need to be removed simply because it is present. Removal may be considered if it causes symptoms, obstructs an airway, continues to grow, or cannot be confidently distinguished from cancer.

Infectious Nodules

Treatment is directed at the infection when one is identified. Depending on the cause, treatment may involve antibiotics, antifungal medication, or medication for tuberculosis.

Some fungal granulomas represent old, inactive infections and do not require treatment. The decision depends on symptoms, immune status, test results, geographic exposure, and evidence of active disease.

Note: Follow-up imaging may be used to confirm that an infectious nodule shrinks or resolves.

Inflammatory Nodules

Inflammatory nodules may improve when the underlying disease is treated. Medications may include corticosteroids, immune-modifying drugs, or other condition-specific therapies.

Treatment should not begin solely because a nodule appears inflammatory. Infection may need to be excluded before immune-suppressing medication is used.

Cancerous Nodules

When a nodule is confirmed or strongly suspected to be lung cancer, treatment depends on the cancer type, stage, location, molecular characteristics, and the patient’s overall health.

Possible treatments include:

• Surgical removal
• Stereotactic body radiation therapy
• Conventional radiation therapy
• Chemotherapy
• Targeted therapy
• Immunotherapy
• A combination of treatments

A small, localized non-small cell lung cancer may be treated with surgery. The surgeon may remove a wedge, lung segment, or lobe along with nearby lymph nodes.

Stereotactic body radiation therapy may be used for some early-stage cancers when surgery is not appropriate. It delivers focused radiation to the tumor over a limited number of treatments.

If cancer has spread beyond the lung, systemic treatments such as chemotherapy, targeted therapy, or immunotherapy may be needed. Tumor biomarker testing can help determine whether a targeted medication or immunotherapy is appropriate.

Can a Lung Nodule Go Away?

Some lung nodules shrink or disappear. This is most likely when the nodule is caused by a temporary infection, inflammation, bleeding, or a small area of collapsed lung.

Other benign nodules remain visible indefinitely. A healed granuloma or scar may stay the same size for many years and never cause symptoms.

A nodule should not be assumed to be harmless because it might go away. When follow-up imaging is recommended, completing the scan is the only reliable way to see whether the nodule has resolved, remained stable, or grown.

Note: Cancerous nodules generally do not disappear without treatment, although their apparent size can vary slightly because of imaging technique or surrounding inflammation.

Can Lung Nodules Grow Without Being Cancer?

Yes. Growth increases concern, but it does not automatically prove that a nodule is malignant.

Benign nodules may enlarge because of:

• Active infection
• Increasing inflammation
• Fungal disease
• Autoimmune disease
• Bleeding
• Changes within a benign tumor

The rate and pattern of growth provide useful information. An infectious nodule may change quickly and improve after treatment. Some cancers grow over months, while certain subsolid cancers develop slowly over several years.

Note: Meaningful growth usually leads to additional evaluation rather than an immediate assumption of cancer.

What Does It Mean When a Nodule Is Stable?

A stable nodule has shown no meaningful change on comparison imaging. Stability is usually reassuring. For a solid nodule, stability over a suitable period may strongly support a benign diagnosis. However, the required monitoring period depends on the circumstances.

Ground-glass and part-solid nodules can grow more slowly than typical solid cancers. Persistent subsolid nodules may therefore require longer surveillance before follow-up can safely stop.

The comparison must be made using appropriate imaging. A small nodule seen on thin-section CT may not be accurately compared with an older chest X-ray.

Lung Nodule Follow-Up Guidelines

Several professional organizations publish recommendations for lung nodule management. The appropriate system depends partly on how the nodule was found.

Incidental nodules are those discovered on imaging performed for another reason. Screen-detected nodules are found during a formal lung cancer screening program. These groups may be managed under different guidelines.

Recommendations generally consider:

• Nodule size
• Solid, ground-glass, or part-solid density
• Single or multiple nodules
• Patient age
• Smoking and cancer risk
• Suspicious imaging features
• Growth
• Prior cancer
• Immune system status
• Symptoms

Guidelines do not apply equally to everyone. Some incidental nodule recommendations are designed for adults over a certain age and may not apply to people with known cancer, severe immune suppression, or symptoms suggesting an active infection.

The radiology report often includes a specific recommendation. The ordering clinician should review that recommendation in the context of the patient’s complete medical history.

A plan may include:

• No routine follow-up
• Repeat low-dose CT
• Earlier diagnostic CT
• PET/CT
• Referral to pulmonology
• Referral to thoracic surgery
• Bronchoscopy or needle biopsy
• Surgical removal

Note: The recommended interval should be recorded clearly. Missed follow-up can delay the diagnosis of a growing cancer, while unnecessary testing can expose patients to avoidable procedures and anxiety.

Understanding a Lung Nodule Report

Radiology reports contain medical terms that can be difficult to interpret. Important details may include the following.

Nodule Size

Size is usually reported in millimeters. One centimeter equals 10 millimeters. Reports may list two dimensions, three dimensions, or an estimated average diameter. Some may report volume.

A change of only one millimeter does not always represent true growth. Measurement can vary depending on slice thickness, software, breathing, and the observer.

Nodule Location

The report may identify:

• Right or left lung
• Upper, middle, or lower lobe
• Central or peripheral location
• Relationship to a fissure, pleura, airway, or blood vessel

Note: Precise location helps determine whether bronchoscopy, needle biopsy, or surgery would be the most practical approach if tissue sampling is needed.

Attenuation

Attenuation describes how dense the nodule appears. Terms include solid, ground-glass, subsolid, and part-solid.

Margins

The report may describe the edges as smooth, irregular, lobulated, or spiculated.

Calcification

The presence and pattern of calcium may be reported. A benign calcification pattern can lower concern.

Comparison

A report may say the nodule is new, unchanged, increased, decreased, or unable to be compared because previous images are unavailable. “Stable” is reassuring, while “new” or “increased” generally requires closer attention.

Recommended Follow-Up

The impression section usually summarizes the most important findings and recommendations. It may suggest a specific CT interval, PET/CT, or consultation. Patients should ask who is responsible for ordering the follow-up scan and how they will receive the results.

Questions to Ask Your Healthcare Provider

After a nodule is found, useful questions include:

• How large is the nodule in millimeters?
• Is it solid, ground-glass, or part-solid?
• Are the borders smooth or irregular?
• Is there calcification or fat within it?
• Was it visible on any previous scan?
• Has it grown?
• What is my estimated risk that it is cancer?
• Do I need another CT scan?
• When should the follow-up scan occur?
• Should the scan use a low-dose technique?
• Would PET/CT provide useful information?
• Do I need to see a pulmonologist?
• Is biopsy recommended now or only if the nodule changes?
• What symptoms should prompt earlier evaluation?
• Who will track the follow-up plan?

Note: Writing down the recommended date and setting a reminder can reduce the chance of missed surveillance.

When to See a Pulmonologist

A pulmonologist specializes in diseases of the lungs and respiratory system. Referral may be appropriate when:

• The nodule is large
• The nodule is growing
• It has suspicious margins
• It is part-solid
• Multiple nodules require evaluation
• PET/CT or biopsy is being considered
• The patient has a significant smoking history
• There is a history of cancer
• Symptoms are present
• The radiology recommendation is unclear
• The patient has complex lung disease
• Follow-up decisions require individualized risk assessment

Note: Some hospitals have dedicated lung nodule clinics. These programs coordinate imaging review, risk assessment, surveillance, biopsy, surgery, and communication between specialists.

When to Seek Prompt Medical Attention

A small lung nodule itself rarely creates an emergency. However, certain symptoms require prompt assessment because they may indicate bleeding, infection, a blood clot, a collapsed lung, heart disease, or another serious condition.

Seek urgent medical care for:

• Coughing up more than a small streak of blood
• Sudden or severe shortness of breath
• New chest pain, especially with breathing
• Blue or gray lips
• Fainting or severe weakness
• Confusion
• High fever with breathing difficulty
• Rapidly worsening respiratory symptoms

Note: A persistent cough, unexplained weight loss, recurring pneumonia, hoarseness, or ongoing shortness of breath should also be discussed with a healthcare provider, even when immediate emergency care is not required.

Reducing the Risk of Lung Cancer

Not every lung nodule can be prevented. However, several steps can reduce the risk of lung cancer and other lung diseases.

Stop Smoking

Stopping smoking is the most important step for people who currently smoke. The risk of lung cancer decreases over time after quitting, although former smokers may remain at increased risk compared with people who never smoked.

Nicotine replacement, prescription medications, counseling, quitlines, and structured cessation programs can improve the likelihood of success.

Test the Home for Radon

Radon is an invisible radioactive gas that can accumulate in homes. Long-term exposure increases lung cancer risk. Home testing is the only way to know whether radon levels are elevated. Mitigation systems can reduce high indoor levels.

Limit Occupational Exposures

Workplace exposure to asbestos, silica, diesel exhaust, arsenic, chromium, nickel, and other carcinogens may increase lung cancer risk.

Employees should follow safety procedures and use appropriate protective equipment. Occupational health professionals can help evaluate past or ongoing exposure.

Complete Eligible Lung Cancer Screening

People who meet current screening criteria should discuss annual low-dose CT with a healthcare provider. Screening is intended for individuals at increased risk because of age and smoking history.

Screening should occur through a structured program capable of tracking findings, arranging follow-up, and helping participants stop smoking.

Keep Follow-Up Appointments

When surveillance is recommended, completing each scan on schedule is essential. A nodule may cause no symptoms even if it is changing.

Follow-up should continue until the healthcare team determines that the nodule is stable, resolved, benign, or requires another form of evaluation.

Coping With Anxiety About a Lung Nodule

Uncertainty can make the period between scans stressful. Some people assume that any spot in the lung must be cancer, while others become frustrated when clinicians recommend observation rather than immediate removal.

Observation is not the same as ignoring the nodule. For many small nodules, surveillance is the safest approach because invasive procedures carry real risks and may not be justified when the probability of cancer is low.

Practical steps that may help include:

• Requesting a plain-language explanation of the report
• Writing down the follow-up plan
• Obtaining copies of prior imaging
• Asking how the cancer risk was estimated
• Avoiding unverified online interpretations
• Discussing persistent anxiety with the healthcare team
• Seeking a second opinion when recommendations remain unclear
• Using a lung nodule clinic when available

Note: A clear plan can make uncertainty more manageable. Patients should know what test comes next, when it should occur, and what findings would change the plan.

Common Misunderstandings About Lung Nodules

Every Lung Nodule Is Cancer

Most lung nodules are benign. A nodule should be evaluated appropriately, but its discovery is not the same as a cancer diagnosis.

A Small Nodule Can Be Felt

Small nodules generally cannot be felt and do not create a physical sensation. Chest pain or shortness of breath usually has another explanation.

No Symptoms Means No Cancer

Early lung cancer may cause no symptoms. Imaging characteristics and changes over time are more useful than the absence of symptoms when evaluating a nodule.

A Positive PET Scan Confirms Cancer

Infection and inflammation can also produce increased PET activity. Tissue sampling may still be required.

A Negative PET Scan Rules Out Cancer

Small nodules and slow-growing cancers may not absorb enough tracer to appear strongly positive. A negative result must be interpreted in context.

All Growing Nodules Are Cancer

Infections and inflammatory conditions can grow or change. Growth requires evaluation but does not establish malignancy.

All Stable Nodules Are Harmless

Stability is reassuring, but the required observation period depends on whether the nodule is solid or subsolid. Some ground-glass and part-solid cancers grow slowly.

Biopsy Is Always the Best Next Step

Biopsy can cause bleeding, pneumothorax, or an inconclusive result. For a very small, low-risk nodule, follow-up CT may provide more benefit with less risk.

Nodules Should Always Be Removed

Surgery is not necessary for every nodule. Removal is usually reserved for nodules that are cancerous, highly suspicious, symptomatic, growing, or uncertain after other testing.

Final Thoughts

A lung nodule is a common imaging finding, and most are caused by benign conditions such as old infections, inflammation, or scar tissue. The most important details are the nodule’s size, density, shape, growth pattern, and the patient’s personal risk factors.

Some nodules require no further testing, while others need CT surveillance, PET imaging, biopsy, or treatment. Do not ignore a recommended follow-up scan simply because you feel well.

Review the radiology report with your healthcare provider, locate previous imaging when possible, and make sure you understand who will arrange the next step and when it should occur.